Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table 1 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma
  1. Home
  2. Publications
  3. Supplementary Table 1 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma

Supplementary Table 1 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma

Authors:
  • HAHazem Abdullah
    Hazem Abdullah
  • IUIn Hwa Um
    In Hwa Um
  • GSGrant D. Stewart
    Grant D. Stewart
  • CJChang Wook Jeong
    Chang Wook Jeong
  • CKCheol Kwak
    Cheol Kwak
  • KMKyung Chul Moon
    Kyung Chul Moon
  • ALAlexander Laird
    Alexander Laird
  • EFElena Frangou
    Elena Frangou
  • TETim Eisen
    Tim Eisen
  • AMAngela Meade
    Angela Meade
  • DHDavid J. Harrison
    David J. Harrison

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.32702061
Abstract
Comparison of prognostic model discrimination with and without the P21+/MCM2− biomarker
Keywords
  • ARTIFICIAL INTELLIGENCE & MACHINE LEARNING
  • BIOMARKERS
  • PROTEIN BIOMARKERS
  • CELL CYCLE
  • CDKS AND CDK INHIBITORS
  • CELL CYCLE CHECKPOINTS
  • CELL DEATH AND SENESCENCE
  • CELLULAR AGING AND SENESCENCE
  • CHEMOTHERAPY
  • ADJUVANT CHEMOTHERAPY
  • GENITOURINARY CANCERS
  • RENAL CANCER
  • PROGNOSTIC BIOMARKERS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.